176 related articles for article (PubMed ID: 34624822)
1. Synthesis and evaluation of tetrahydroisoquinoline derivatives against Trypanosoma brucei rhodesiense.
Cullen DR; Gallagher A; Duncan CL; Pengon J; Rattanajak R; Chaplin J; Gunosewoyo H; Kamchonwongpaisan S; Payne A; Mocerino M
Eur J Med Chem; 2021 Dec; 226():113861. PubMed ID: 34624822
[TBL] [Abstract][Full Text] [Related]
2. 2-Arylpaullones are selective antitrypanosomal agents.
Ryczak J; Papini M; Lader A; Nasereddin A; Kopelyanskiy D; Preu L; Jaffe CL; Kunick C
Eur J Med Chem; 2013 Jun; 64():396-400. PubMed ID: 23648975
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis.
Wenzler T; Yang S; Braissant O; Boykin DW; Brun R; Wang MZ
Antimicrob Agents Chemother; 2013 Nov; 57(11):5330-43. PubMed ID: 23959303
[TBL] [Abstract][Full Text] [Related]
4. Development of Novel Isoindolone-Based Compounds against Trypanosoma brucei rhodesiense.
Silva DG; Feijens PB; Hendrickx R; Matheeussen A; Grey L; Caljon G; Maes L; Emery FS; Junker A
ChemistryOpen; 2021 Sep; 10(9):922-927. PubMed ID: 34553828
[TBL] [Abstract][Full Text] [Related]
5. Novel functionalized melamine-based nitroheterocycles: synthesis and activity against trypanosomatid parasites.
Baliani A; Peal V; Gros L; Brun R; Kaiser M; Barrett MP; Gilbert IH
Org Biomol Chem; 2009 Mar; 7(6):1154-66. PubMed ID: 19262935
[TBL] [Abstract][Full Text] [Related]
6. Tractable Quinolone Hydrazides Exhibiting Sub-Micromolar and Broad Spectrum Antitrypanosomal Activities.
Chirwa KA; Francisco KR; Dube PS; Park H; Legoabe LJ; Teixeira TR; Caffrey CR; Beteck RM
ChemMedChem; 2024 May; 19(9):e202300667. PubMed ID: 38326914
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro antitrypanosomal evaluation of novel 6-heteroarylidene-substituted quinolone derivatives.
Angula KT; Legoabe LJ; Swart T; Hoppe HC; Beteck RM
Eur J Med Chem; 2022 Jan; 227():113913. PubMed ID: 34656043
[TBL] [Abstract][Full Text] [Related]
8. Activity of diphenyl ether benzyl amines against Human African Trypanosomiasis.
Hagen JP; Darner G; Anderson S; Higgins K; Leas DA; Mitra A; Mashinson V; Wol T; Vera-Esquivel C; Belter B; Cal M; Kaiser M; Wallick A; Warner RC; Davis PH
Bioorg Chem; 2020 Apr; 97():103590. PubMed ID: 32179269
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationships of new quinolone-type molecules against Trypanosoma brucei.
Hiltensperger G; Jones NG; Niedermeier S; Stich A; Kaiser M; Jung J; Puhl S; Damme A; Braunschweig H; Meinel L; Engstler M; Holzgrabe U
J Med Chem; 2012 Mar; 55(6):2538-48. PubMed ID: 22376072
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, DNA binding and antitrypanosomal activity of benzimidazole analogues of DAPI.
Farahat AA; Bennett-Vaughn C; Mineva EM; Kumar A; Wenzler T; Brun R; Liu Y; Wilson WD; Boykin DW
Bioorg Med Chem Lett; 2016 Dec; 26(24):5907-5910. PubMed ID: 27843114
[TBL] [Abstract][Full Text] [Related]
11. From human immunodeficiency virus non-nucleoside reverse transcriptase inhibitors to potent and selective antitrypanosomal compounds.
Venkatraj M; Ariën KK; Heeres J; Joossens J; Dirié B; Lyssens S; Michiels J; Cos P; Lewi PJ; Vanham G; Maes L; Van der Veken P; Augustyns K
Bioorg Med Chem; 2014 Oct; 22(19):5241-8. PubMed ID: 25199582
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of bicyclic amines and their activities against Trypanosoma brucei rhodesiense and Plasmodium falciparum K1.
Weis R; Berger H; Kaiser M; Brun R; Saf R; Seebacher W
Arch Pharm Res; 2008 Jun; 31(6):688-97. PubMed ID: 18563349
[TBL] [Abstract][Full Text] [Related]
13. DNA binding affinity of bisguanidine and bis(2-aminoimidazoline) derivatives with in vivo antitrypanosomal activity.
Dardonville C; Barrett MP; Brun R; Kaiser M; Tanious F; Wilson WD
J Med Chem; 2006 Jun; 49(12):3748-52. PubMed ID: 16759117
[TBL] [Abstract][Full Text] [Related]
14. The discovery of novel antitrypanosomal 4-phenyl-6-(pyridin-3-yl)pyrimidines.
Robinson WJ; Taylor AE; Lauga-Cami S; Weaver GW; Arroo RRJ; Kaiser M; Gul S; Kuzikov M; Ellinger B; Singh K; Schirmeister T; Botana A; Eurtivong C; Bhambra AS
Eur J Med Chem; 2021 Jan; 209():112871. PubMed ID: 33070078
[TBL] [Abstract][Full Text] [Related]
15. Bisguanidine, bis(2-aminoimidazoline), and polyamine derivatives as potent and selective chemotherapeutic agents against Trypanosoma brucei rhodesiense. Synthesis and in vitro evaluation.
Dardonville C; Brun R
J Med Chem; 2004 Apr; 47(9):2296-307. PubMed ID: 15084128
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and antitrypanosomal activities of 2,6-disubstituted-4,5,7-trifluorobenzothiophenes.
Bhambra AS; Edgar M; Elsegood MRJ; Li Y; Weaver GW; Arroo RRJ; Yardley V; Burrell-Saward H; Krystof V
Eur J Med Chem; 2016 Jan; 108():347-353. PubMed ID: 26698538
[TBL] [Abstract][Full Text] [Related]
17. Bistacrines as potential antitrypanosomal agents.
Schmidt I; Göllner S; Fuß A; Stich A; Kucharski A; Schirmeister T; Katzowitsch E; Bruhn H; Miliu A; Krauth-Siegel RL; Holzgrabe U
Bioorg Med Chem; 2017 Aug; 25(16):4526-4531. PubMed ID: 28698054
[TBL] [Abstract][Full Text] [Related]
18. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.
Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB
Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695
[TBL] [Abstract][Full Text] [Related]
19. Identification and Characterization of FTY720 for the Treatment of Human African Trypanosomiasis.
Jones AJ; Kaiser M; Avery VM
Antimicrob Agents Chemother; 2015 Dec; 60(3):1859-61. PubMed ID: 26666915
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antitrypanosomal activities of novel pyridylchalcones.
Bhambra AS; Ruparelia KC; Tan HL; Tasdemir D; Burrell-Saward H; Yardley V; Beresford KJM; Arroo RRJ
Eur J Med Chem; 2017 Mar; 128():213-218. PubMed ID: 28189085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
